Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal cell carcinoma
Pharma
Welireg's RCC wins could pad Merck's post-Keytruda sales
The combination win with Merck's own Keytruda represented more of a definite victory, according to one group of analysts.
Fraiser Kansteiner
,
Eric Sagonowsky
Oct 28, 2025 3:00pm
Merck's Welireg again comes up short in OS but excels in PFS
Sep 13, 2024 8:00am
BMS' Opdivo, Aveo's Fotivda fail as combo in kidney cancer
Jul 18, 2024 4:26pm
FDA signs off on 2nd approval for Merck's Welireg
Dec 15, 2023 11:33am
Merck looks to broaden Welireg's reach in kidney cancer
Aug 18, 2023 11:12am
Lonza signs on with Allarity to produce cancer drug candidate
Sep 23, 2021 3:23pm
